ARKG 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

ARKG

ARK Genomic Revolution ETF

收盤價 11月5日 11:39 AM ET（韓國 11/6 01:39）

$49.69

+0.18 ▲ +0.36%

上升通道阻力線 61.68 支撐線 49.15 維持連續3天同一條線由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.75%	Return% 1Y ⓘ	59.04%	Total Holdings ⓘ	35	Perf Week ⓘ	-9.36%	Volume ⓘ	4,239,228
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$2.15B	Return% 3Y ⓘ	30.57%	NAV ⓘ	$49.57	Perf Month ⓘ	-3.98%	Avg Volume ⓘ	4.71M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	-	Return% 5Y ⓘ	-8.01%	52W High ⓘ	-15.54%	Perf Quarter ⓘ	22.54%	Rel Volume ⓘ	0.9
Active/Passive ⓘ	Active	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	11.6%	52W Low ⓘ	101.99%	Perf Half Y ⓘ	59.98%	Prev Close ⓘ	$49.51
IPO ⓘ	2014/10/31	Flows% 1M ⓘ	2.08%	Return% SI ⓘ	8.48%	RSI (14) ⓘ	48.85	Perf YTD ⓘ	71.52%	Price ⓘ	$49.69
Beta ⓘ	1.74	Flows% 3M ⓘ	7.71%	Flows% YTD ⓘ	8.88%	Flows% 1Y ⓘ	6.38%	Perf Year ⓘ	68.44%	Volatility(W/M) ⓘ	5.67% 5.02%
SMA20 ⓘ	-0.01%	SMA50 ⓘ	-0.46%	SMA200 ⓘ	32.11%	ATR ⓘ	2.64

ETF 簡介

ARK Genomic Revolution ETFARKG | CBOE | 主動管理型查看深度分析

ARK Genomic Revolution ETF seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

ARKG ETF 一覽

0.75% 越低越好

$2.1B 管理資產

35檔

掛牌日 2014年

管理方式主動管理

發行公司 ARK Invest

主要持有標的持有 35 檔

前 10 大持股占 基金的 59%